Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neuro... (lations David Walsey ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index

Date:9/26/2007

lations

David Walsey 212.301.7228

Director, Corporate Communications

Arena Pharmaceuticals, Inc.

858.453.7200, ext. 1682

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. San Diego firm selected for Madison Wi-Fi project
4. Milwaukee-based eFilm software selected by InSight Health, announces Workstation upgrade
5. Berbee Selected by Microsoft as Featured Speaker for New Product Launch
6. NASDAQ will continue to list Merge
7. NASDAQ grants Merge more time for compliance
8. NASDAQ will continue to list Merge
9. No word on NASDAQ extension for Merge
10. NASDAQ puts Merge on notice again
11. Wisconsin ranks 30th in New Economy index

Post Your Comments:

Breaking Biology Technology:Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2 Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2 Successful Stem Cell Therapy for Treatment of Eye Disease 2 Successful Stem Cell Therapy for Treatment of Eye Disease 3 Successful Stem Cell Therapy for Treatment of Eye Disease 4 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3

[0] Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer [0] Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology [0] Successful Stem Cell Therapy for Treatment of Eye Disease [0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products

Other Biology Technology:The NCIIA Recognizes Collegiate Biomedical Engineering Innovations 2 The NCIIA Recognizes Collegiate Biomedical Engineering Innovations 3 Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region 2 Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region 3 Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco 2 Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco 3

The NCIIA Recognizes Collegiate Biomedical Engineering Innovations Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco

Breaking Biology News(10 mins):Princeton scientists find way to catalog all that goes wrong in a cancer cell 2 New engineering institute to modify, develop technology for the global poor 2 New engineering institute to modify, develop technology for the global poor 3 Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 1 Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 2 Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 3 Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 4 Biotel Announces Fourth Quarter and Year End Results 14304 1 Biotel Announces Fourth Quarter and Year End Results 14304 2 United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 1 United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 2 United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 3

[0] NASA news highlights at American Geophysical Union Meeting [0] Princeton scientists find way to catalog all that goes wrong in a cancer cell [0] New engineering institute to modify, develop technology for the global poor

Other Biology News:Researchers bridge the 'terahertz gap' with new tunable metamaterial 2 Researchers bridge the 'terahertz gap' with new tunable metamaterial 3 Prototype terahertz imager promises biochem advances 2 Mental stress reduces blood flow to the heart in patients with gene variation 2 Mental stress reduces blood flow to the heart in patients with gene variation 3

Researchers bridge the 'terahertz gap' with new tunable metamaterial Prototype terahertz imager promises biochem advances Mental stress reduces blood flow to the heart in patients with gene variation

Biology Products:

Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents Rabbit Anti-TetR Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.